In order to evaluate whether the anti-cancer properties of TE-64562 were translatable to anti-tumor activity in vivo, MDA-MB-231 xenograft tumors were grown in the subcutaneous flank region of nude mice which were treated bi-weekly with the TE-64562 peptide Tat peptide or vehicle. The gene discussed is TAT; the disease is cancer.